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Abstract: OBJECTIVES
Evidence of the accuracy of predictive tests in confirming the presence and grade of
upper urinary tract urothelial carcinomas (UUTUC) is limited. We present the largest
series evaluating the diagnostic value of pre- and intraoperative parameters in the
detection of UUTUC.
MATERIALS AND METHODS
We retrospectively analysed records of patients who underwent diagnostic
ureteroscopy between 2005 and 2014 for suspected UUTUC. Preoperative workup
included voided urine cytology and CT imaging. Intra-operative assessments involved
ureteroscopy to directly visualise suspicious lesions, and where possible selective
cytology and biopsy. Primary outcomes were the visualisation of UUTUC and
histopathological confirmation of tumour.
RESULTS
100/160 (63%) of patients presenting with suspected upper tract malignancy had
UUTUC. Voided and selective urine cytology and CT individually predicted UUTUC
with a sensitivity/specificity of 63%/67%, 76%/73% and 95%/26% respectively. 40/48
(83%) of patients who had abnormal CT and abnormal voided urine cytology had
UUTUC, while 100% of those with normal CT and normal voided cytology (investigated
for ongoing symptoms) were normal. Comparing endoscopic biopsy to
nephrouretectomy specimen grade, 19 (46%), 18 (44%), and 4 (10%) were identical,
upgraded and downgraded respectively.
CONCLUSIONS
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
Pre-operative investigations can predict UUTUCs. When these investigations were
normal, the risk of UUTUC is negligible. In selective patients with abnormal
investigations, ureteroscopy should be performed to confirm and predict the grade of
UUTUC, in order to guide future management. Selective cytology is unlikely to
signfiicantly contribute to the diagnostic workup of UUTUC.
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Dear Editor,  
 
We are grateful to you and the reviewers for your comments on our manuscript, and 
have addressed all the issues that were raised. We believe the manuscript has been 
improved as a result, and would like to thank you all for your efforts. 
 
Please find attached to each comment below our corresponding reply in blue. 
 
We hope that our amendments are found to be satisfactory and look forward to your 
decision as to whether this manuscript is now ready for publication in the World 






On behalf of all the authors. 
 
 
COMMENTS FOR THE AUTHOR: 
 
Reviewer #1: How was chosen group of 186 patients indicated for 
cytology/ureteroscopy?  
We thank the reviewer for their feedback. The study population consisted of 186 
consecutive patients who underwent ureteroscopy at our centre between 2005 and 
2014. We have clarified the methods to highlight how these patients suspected of 
malignancy were selected:  
 
“Patients were referred to our urology service with a suspicion of malignancy based 
on urinary tract symptoms (including haematuria, loin pain, recurrent urinary tract 
infections). Following initial evaluation with flexible cystoscopy and upper tract 
imaging, patients were counseled and offered further upper tract assessment with rigid 
and/or flexible URS if they had abnormal cytology [(n=59, 51%)], abnormal CT 
[(n=135, 85%)], ongoing haematuria [(n=3, 2%)], or abnormality from ureteric orifice 
at flexible cystoscopy [(n=2, 1%]. 
 
What does mean „for suspected UUUTC"?  
Those patients who met the above criteria, as now clarified in the manuscript. 
 
Abnormal CT?  
An abnormal CT was defined as one which demonstrated a filling defect in the 
excretory phase, a visible mass in the region of the pelvis or ureter, a thickening of the 
ureteric wall, peri-ureteric stranding, hydroureter/hydronephrosis or a ureteric 
stricture. This has been clarified in the methods.  
 
Why it was indicated?  
CT is a routine investigation at our institute with suspected UUTUC; this has been 
highlighted in the amended manuscript. A non-contrast CT may have been chosen on 
occasions where renal impairment or contrast allergy restricted the use of a CT 
Response to reviewer's comments Click here to download Manuscript Responses_030716.doc 
Click here to view linked References
urogram.    
 
Why 26 cases were excluded? 
The reasons for the 26 patients excluded has been reiterated in the amended 
manuscript, and remains in Figure 1.  
 
26 patients were excluded in this study. 3 patients were found to have peri-ureteric 
deposits which were investigated by upper tract imaging and ureteroscopy, but which 
actually resulted from a secondary pancreatic metastasis, local invasion from a large 
bowel malignancy, and a renal cell carcinoma. As these were not transitional cell 
upper urinary tract malignancies we did not seek to skew our data by including their 
findings as part of our evaluation.   
 
To clarify, the remaining 23 patients have been described as unclear or unknown 
ureteroscopy reports, in which the findings of the ureteroscopy and intraoperative 
diagnosis could not be confidently ascertained from the clinical notes. We have 
highlighted the limitations of such retrospective analysis and hence reiterate the need 
for future prospective studies which can further improve the confidence of our results.  
 
 
What type of ureteroscopy - semirigid, flexible? 
We have access to semirigid and flexible ureteroscopes. We usually start with 
semirigid URS to inspect the distal and mid ureter. The flexible URS can then be used 
to check the proximal ureter, renal pelvis and collecting system.  
 
 
Page 3 paragraph the last but tow: (2) hydronephrosis - megaureter is 
probably better term, because no only pelvis is dilated, but mostly ureter as 
well 
We agree and have amended the description to “hydronephrosis/hydroureter”. 
 
Can we really express specificity, if you include to the study only cases with 
any abnormal finding? 
The reviewer highlights an important consideration, which is the need to clarify the 
population to which the sensitivity and specificity figures refer. While the specificity 
often describes the proportion of non-diseased individuals correctly identified within 
the entire population, the findings of our study are of far greater clinical utility to 
urological practitioners. In fact the goal was to check if clinical or radiological 
suspicion is enough to subject a patient to a major surgery in the form of radical 
nephroureterectomy  
The patient population that we have studied and obtained specificities and sensitivities 
for are precisely those at-risk patients who we will be considering to evaluate further. 
While the statistics would not be applicable to the general population at large, they 
should be relevant to any patient in whom UUTUC is clinically and/or radiologically 
suspected (based on the criteria described above). In this way we feel the statistics are 
more relevant and practicably applicable to the urological community.    
 
Conclusion: It is very difficult to follow study step-by-step. There are too many 
questions to scheme of study. I don't find clear understandable conclusion 
important for clinical practise. 
This is an exploratory study evaluating the investigations needed to confirm or 
exclude UUTUC, hence we have looked at several variables in order to evaluate this 
important and complex topic. In addressing the points raised by the reviewer, and 
amending the manuscript, we hope we have further clarified our comprehensive 
evaluation for investigating suspected UUTUC.   
 
Reviewer #2: Authors have done retrospective analysis of 160 cases of 
suspected upper urinary tract urothelial carcinoma (UUTUC) at a single 
center. 100/160  (63%) patient had UUTUC;  diagnoses was based on 
cytology and CT scan findings. Those patients neither had abnormality in 
cytology in voiding urine specimen and also in CT evaluation did not have 
UUTUC.  
I have few questions. 
1. Title is "Can we predict the presence and grade of upper urinary tract 
urothelial carcinoma ?" Authors have not taken etiological factors in account 
(e.g. history of analgesic abuse).  
We thank the reviewer for the feedback. The reviewer is correct that we were unable 
to include a comprehensive list of associated risk factors into our analysis, with the 
important exception of previous bladder TCC. While we establish exposure to 
smoking, pelvic irradiation, excess analgesics, cyclophophasmides certain 
chemicals/dyes as part of the patient’s general risk assessment, it was not possible to 
include all of these parameters in this evaluation. The use of larger scale 
epidemiological studies would have the necessary power to draw the conclusions of 
these associations with the presence of UUTUC. We feel that their exclusion from 
this study would not impact upon the results of detection rates of UUTUC by CT and 
URS. However we have nevertheless reiterated this limitation in the discussion. We 
also feel that the reviewer has highlighted an important improvement in the title of 
our study, and would therefore suggest the amendment which has been made in the 
manuscript.   
 
2. Table-1 shows associated history of bladder TCC in 28%, 45% and 39% of 
benign, malignant and total number of patients respectively. It is important to 
know the grade of bladder tumor and associated carcinoma in situ. Was the 
high grade bladder tumor associated with UUTUC? In other words, is high 
grade bladder urothelial tumor predictive of UUTUC? 
We do have some data (below) which supports the general conclusion that higher 
grade bladder TCCs are associated with UUTUCs. There is a general trend towards 
differing distributions within the categories of bladder TCC (χ2=10.53, p=0.062): 18% 
and 33% of patients with an absence or presence of a UUTUC respectively, having a 
history of CIS, Grade 2 or Grade 3 TCC of the bladder. Furthermore multinomial 
logistic regression analysis for bladder TCC (relative to the absence of any such 
history), revealed, as expected, a significantly lower incidence of Grade 2 disease in 
patients without a UUTUC compared to those with identified UUTUC 
(Exp(B)=0.256, p=0.040).  
 
However given the post-hoc nature of this subgroup analysis which on balance is 
underpowered to reveal the true extent of this relationship, we are more confident in 
describing the general trend of a higher proportion of bladder TCC in our UUTUC 






Total Benign Malignant 
Bladder TCC No previous 
Bladder TCC 
Count 43 55 98 
% within UUTUC 71.7% 55.0% 61.3% 
G1 Count 4 6 10 
% within UUTUC 6.7% 6.0% 6.3% 
G2 Count 3 15 18 
% within UUTUC 5.0% 15.0% 11.3% 
G3 Count 6 18 24 
% within UUTUC 10.0% 18.0% 15.0% 
CIS Count 2 0 2 
% within UUTUC 3.3% 0.0% 1.3% 
Unknown Count 2 6 8 
% within UUTUC 3.3% 6.0% 5.0% 
Total Count 60 100 160 
% within UUTUC 100.0% 100.0% 100.0% 
 
Multinomial Logistic Regression analysis parameter estimates 
Bladder TCCa B Std. Error Wald df Sig. Exp(B) 






G1 Intercept -2.216 .430 26.556 1 .000    
Ben vs. Mal -.159 .677 .055 1 .814 .853 .226 3.213 
G2 Intercept -1.299 .291 19.896 1 .000    
 
Ben vs. Mal -1.363 .664 4.210 1 .040 .256 .070 .941 
G3 Intercept -1.117 .272 16.920 1 .000    
Ben vs. Mal -.852 .513 2.756 1 .097 .426 .156 1.166 
 
a. The reference category is: No bladder TCC. 
 
 
3. What definition was accepted to diagnose "Thickening" of ureteric wall?  
The radiologists typically identified an increase in the size of the ureter as being a 
relative finding to the contralateral ureter, although no precise threshold has been 
established.   
 
4. Table-4 shows two different value of negative biopsy of ureteroscopy (10 
out of 75 and 11/75). It needs correction.  
This has been amended.   
 
5. Did you use narrow band imaging or other methodology during cystoscopy 
and ureteroscopy? Do you think it would have improve further the diagnostic 
yield over combined use of cytology and radiology only? 
Narrow-band imaging is becoming of increasing interest, as an active area of research 
in the diagnosis bladder TCCs, although its general utility has not been widely 
adopted and applicability to upper tract TCCs is less well documented. We did not 
employ the technique for our patients included in this study, although we have 
highlighted the technique as an important additional consideration for future studies 
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INTRODUCTION 
Upper urinary tract urothelial carcinoma (UUTUC) is a rare malignancy, accounting for 5% of all urothelial 
cancers (Siegel et al 2014). Few useful prognostic factors have been established, and the 5-year specific 
survival remains low, at less than 50% for pT2 and pT3 disease, and less than 10% for pT4 disease (Jeldres et al 
2010).  
Radical nephroureterectomy (RNU) with excision of a bladder cuff remains the gold standard treatment for 
UUTUC, regardless of the location of the tumour in the upper urinary tract (Margulis et al 2009); however 
improvements in endoscopic techniques have led to increasing number of patients being managed 
endoscopically.  
The natural history of UUTUC is still poorly understood, and accurate risk stratification remains elusive. 
Attempts have been made to incorporate clinical and pre-operative parameters into risk stratification tools 
(Chitale et al 2008; Williams et al 2008), which included urine cytology and imaging studies such as Multi-
Detector Computed Tomography Urography (MDCTU or CT) (Dillman et al 2008). This is in addition to 
ureteroscopic findings, which have shown to be important in identifying and predicting the progression of 
UUTUC (Chen et al 2000). Early diagnosis is crucial to tailor individualised management plans and improve 
outcomes, and delays between diagnosis and surgery have shown to have negative implications on disease 
recurrence and cancer-specific mortality (J N Lee et al 2014).  
Our study evaluates the diagnostic and prognostic value of the pre-operative and intra-operative parameters 
utilised in the investigation of UUTUC.  
PATIENTS AND METHODS 
Study Population: We retrospectively analysed consecutive patients who underwent ureteroscopy (URS) at a 
single centre between January 2005 and March 2014. Patients were referred to our urology service with a 
suspicion of malignancy based on urinary tract symptoms (including haematuria, loin pain, recurrent urinary 
tract infections). Following initial evaluation with flexible cystoscopy and upper tract imaging, patients were 
counselled and offered further upper tract assessment with rigid and/or flexible URS if they had abnormal 
cytology, abnormal CT, ongoing haematuria, or abnormality from ureteric orifice at flexible cystoscopy. The 
diagnosis of UUTUC was based on the presence of distinct papillary or solid tumours observed on URS, and 
where available, histopathology results from ureteroscopic biopsies and nephroureterectomy specimens. The 
medical charts, radiological, cytological and pathological reports for all patients were independently reviewed 
by two authors (HD and SP). The clinico-pathological parameters collected were: gender; age and clinical 
presentations at diagnosis; previous history of bladder cancer; and patient treatment (endoscopic, radical 
surgery or palliation). 26 patients were excluded due to other malignancies or incomplete information (Figure 
1).  
Pre-operative investigations: Both pre-operative ‘voided’ and intra-operative ‘selective’ cytology reports were 
assessed. Selective cytology was obtained during ureteroscopic washings of the renal pelvis and/or ureters. 
Cytology samples were classified as negative, atypical, and positive. Positive cytology was used when a high 
proportion of cells carried a high index of suspicion for malignant UUTUC, possessing exceedingly abnormal 
morphology. Atypical cytology was defined by the presence of a few abnormal cells, insufficient to exclude 
malignancy. CT reports were obtained prior to URS and three main outcomes were evaluated: the presence or 
absence of (1) a filling defect or a soft tissue mass; (2) hydronephrosis/hydroureter; and (3) thickening of the 
ureteric wall. As such, an abnormal CT was defined as one which demonstrated a filling defect in the excretory 
phase, a visible mass in the region of the pelvis or ureter; hydroureter/hydronephrosis or a ureteric stricture; a 
thickening of the ureteric wall with or without peri-ureteric stranding. 
For each of these variables, the sensitivities and specificities were calculated, with respect to the presence of 
UUTUC, and for nephroureterectomy specimens with respect to tumour invasiveness. 
Histopathological assessment: All biopsies and histopathological specimens were reviewed by our institution’s 
histopathologists, based on 2004 World Health Organisation’s (WHO) and International Society of 
Uropathologists (ISUP) grading system (Jones and Cheng 2006, J.N. Eble et al 2004). PUNLMP, grade 1 and 2 
were defined as low-grade, while Grade 3 was classified as high-grade disease. Pathology stage was used as a 
marker of tumour invasiveness, with invasive tumours defined as pT1 and above. 
Statistical Analysis: We performed Pearson’s Chi-squared tests to evaluate the relationship between pre-
operative variables, and intra-operative variables, and calculated the sensitivities and specificities. We also 
conducted two separate multivariable regression analyses and calculated the corresponding Area Under the 
Curve. All results were two-sided and deemed statistically significant if the p value < 0.05. Statistical analyses 
were performed using IBM SPSS Statistics for Windows®, Version 22.0. Armonk, NY: IBM Corp. 
RESULTS 
Patients: Out of 186 patients who underwent diagnostic URS, 160 patients were included in the analysis 
(Figure 1). The patient characteristics, demographics and presenting symptoms were outlined in Table 1. 
Patients underwent diagnostic URS (rigid +/- flexible) if they had abnormal cytology (n=59, 51%), abnormal CT 
(n=135, 85%), ongoing haematuria (n=3, 2%), or abnormality from ureteric orifice at flexible cystoscopy (n=2, 
1%). The proportion of patients who underwent each diagnostic investigation is shown in Supplemental Figure 
1. 
100 (63%) patients had UUTUC confirmed at URS and/or after nephroureterectomy (Figure 1). Malignancy was 
defined by the presence of UUTUC when directly visualised, and where available, from biopsies taken 
endoscopically and/or confirmed after nephroureterectomy.  
There was a general trend towards differing rates of previous bladder TCC between the benign cohort and 
those found to have an UUTUC (χ2=10.53, p=0.062). 33% and 18% of patients with or without an UUTUC had a 
prior history of CIS, Grade 2 or Grade 3 TCC of the bladder (see Supplemental Table 1). 
Pre-operative investigations: Voided urine cytology was obtained in 116 (73%) patients; of which, 57 (49%) 
were negative, 31 (27%) were atypical and 28 (24%) were positive (Supplemental Figure 2a). Abnormal (i.e. 
atypical or positive) voided urine cytology predicted the presence of UUTUC (χ2=10.165, p=0.006) with a 
sensitivity and specificity of 63% and 67% respectively, and predicted tumour invasiveness (χ2=6.67, p=0.048). 
Figure 2 shows the proportions of each voided cytology parameter relative to the final histopathological grade. 
Voided urine cytology was able to predict G2 and G3 disease on final histopathological specimens at 43% and 
80% sensitivities respectively. In addition, voided urine cytology was also able to significantly predict selective 
cytology obtained endoscopically (Supplemental Figure 2c), with only 10 extra malignancies being identified by 
selective ureteroscopic washings. Of note, all of these 10 additional patients also had abnormalities on CT (8 
with filling defects or mass, 1 with ureteric thickening and 1 with hydronephrosis/hydroureter). 
All 160 patients who underwent a URS had a CT, which identified a filling defect or mass in 100 (63%) cases. 
The proportions of each parameter identified on CT imaging, and their respective ability to predict UUTUC is 
summarised in Table 2. Abnormal CT predicted UUTUC with a sensitivity of 95% and specificity of 26% (Table 
2), however CT findings were unable to predict tumour invasiveness (data not shown). Of the three CT 
parameters (filling defect or mass, ureteric thickening or hydronephrosis/hydroureter) evaluated individually, a 
filling defect or soft tissue mass detected on CT was the only significant predictor of malignant status 
(χ2=15.213, p<0.001). Five (25%) patients with normal CTs had UUTUC identified on URS, while 15 (75%) with 
normal CTs were correctly confirmed after URS; 42 (31%) patients with abnormalities on CT had a normal URS. 
UUTUC was detected in 33/39 (85%) patients who had filling defects or mass reported on CT together with 
abnormal voided urine cytology (17/20 with positive cytology, and 16/19 with atypical cytology) (Table 3). 
Similarly 47/55 (85%) patients were identified with UUTUC having had filling defects or mass on CT and 
abnormal selective cytology.  
Eight (17%) patients with positive voided cytology and abnormality on CT demonstrated a benign histology; six 
(75%) of these had an identifiable filling defect or mass on CT.  
Selective Cytology: Selective cytology was obtained during URS in 126 (79%) patients; where 55 (44%), 27 
(21%), and 44 (35%) were reported as negative, atypical and positive respectively. Selective cytology predicted 
UUTUC (χ2=30.866, p<0.001) with a sensitivity and specificity of 76% and 73% respectively, in addition to 
predicting tumour invasiveness (χ2=8.608, p=0.197) (Supplemental Figure 2b). Figure 2 shows the proportions 
of each selective cytology outcome relative to the final grade from nephroureterectomy specimens. The 
prognostic ability of selective cytology was only marginally better than pre-operative voided cytology. In G2 
and G3 nephroureterectomy specimens, the respective sensitivities for selective cytology, was 65% and 96% 
compared with 43% and 80% for voided urine cytology (data not shown).  
Of those with available selective cytology results and subtle CT findings  (hydronephrosis/hydroureter or 
ureteric thickening only) (Table 2): 8 had a benign outcome (with 2 abnormal and 6 negative selective cytology 
results); 8 had a malignant outcome (4 abnormal and 4 negative selective cytology results). 
Ureteroscopic biopsy: Table 4 shows the histopathology from ureteroscopic biopsies and post-
nephroureterectomy specimens, stratified according to grade and stage. Of 75 ureteroscopic biopsies that 
were taken, 65 (87%) had UUTUC present. Of 59 gradable specimens, 38 (64%) were low grade, while 21 (36%) 
were high grade disease; 34 (64%) tumours were invasive, and 19 (36%) were non-invasive. 55 out of 57 (96%) 
nephroureterectomy specimens were identified as malignant; 2 (3%) final cases had previously identified 
malignancy on URS, where the tumour was likely sufficiently removed by biopsy or diathermy rendering the 
final post-nephrouretectomy histopathological diagnosis as benign.  
Ureteroscopic biopsy positively correlated with nephrouretectomy specimen in terms of grade (χ2 = 19.793, 
p=0.071) and stage (χ2=19.950, p=0.336) (Figure 3). Nineteen (43%) and 12 (32%) biopsies matched the grade 
and stage of nephroureterectomy specimens. As expected, the proportion of biopsies that were up-graded and 
up-staged was higher than those down-graded and down-staged (Figure 3). 7 cases of 41 cases which could be 
analysed, were upgraded to G2 or G3 disease  (data not shown).  
Multivariable analysis of pre-operative and Intra-operative variables: Pre-operatively, male gender, age, 
voided urine cytology, and the presence of filling defect or mass on CT imaging were shown to be robust 
independent predictive factors of UUTUC, with the latter demonstrating the highest hazard ratios of 11.7 
(Table 5); AUC 0.816 (95% CI: 0.73-0.90). Ureteric thickening and hydronephrosis/hydroureter on CT were not 
significant independent predictors of UUTUC.  
DISCUSSION 
Our results confirm that, pre-operatively, voided urine cytology and the presence of filling defect or mass on 
CT are important positive finginds in the investigation of suspected UUTUC. In addition to gender and age, they 
were able to independently predict the presence of UUTUC.  
There were high false positive rates particularly from CT investigations and non-specific findings of 
hydronephrosis/hydroureter and ureteric thickening. Specifically, these findings on CT were not able to 
significantly predict the presence of tumour compared to the conclusions of another study (Brien et al 2010). 
The combined sensitivity of voided urine cytology and CT of 85% demands the use of URS to correctly identify 
patients with UUTUC. In contrast, since 100% of those with both a normal CT and normal voided cytology had 
benign findings on URS (Table 3), we would propose that with clinical judgment such patients, individually risk-
stratified, would not require URS in the presence of persisting symptoms. Clearly equivocal results in either 
modality may necessitate further investigation. 
A limited analysis of 6/39 (15%) benign cases after URS, had demonstrated measurable mass or filling defects 
on CT. While the presence of a measurable mass is more indicative of malignancy (approximately 2:1 incidence 
rates in malignant and benign pathology respectively – data not shown), we were unable to identify a cut-off 
size of a mass on CT that would be able to discern between benign and malignant findings. 
As expected, voided urine cytology correlated well with selective cytology, although multivariate analysis 
suggests that selective cytology has statistically superior predictive capability. However, in terms of clinical 
utility, when directly compared to selective cytology this only identified 10 additional malignant cases over 
voided cytology. We found 85% of patients with both abnormal CT and abnormal voided cytology had an 
UUTUC. The same proportion (85%) was identified in those with abnormal CT and abnormal selective cytology. 
Indeed, our results suggest that the addition of selective cytology provides only marginal additional value. 
Furthermore, the combination of an abnormal selective cytology with subtle CT findings (thickening or 
hydronephrosis/hydroureter alone) was not sufficient to predict the presence of UUTUC, and direct visual 
observation and/or confirmation with biopsy was critical in determining clinical need for nephrouretectomy in 
these cases. 
Previous descriptions have been made correlating histology of ureteroscopic biopsies with 
nephroureterectomy specimens but these have been limited by small case numbers (Chitale et al 2008). We 
present the largest such series, and demonstrate that biopsies do correlate with high grade disease, and 
relatively few cases require upgrading, which may reflect more systematic technical approaches to the 
biopsying of tumours.  
In the absence of sufficient staging data, we attempted to identify the predictive capacity of a high grade 
biopsy to predict UUTUC invasiveness; however after multivariate analysis a high grade biopsy was unable to 
predict UUTUC invasiveness in our series. Smith and colleagues (Smith et al 2011) suggested that biopsy grade 
may still be subject to a non-negligible rate of sampling error, particularly with larger tumours, which may in 
part, explain these results. It is possible that employing narrow-band imaging technology, better characterized 
for the diagnosis of bladder TCC, may still further improve the identification and biopsy of suspected UUTUC, 
and this will be an important variable to consider in future studies as these ureteroscopes become more 
widely available.    
The study is limited by variations between reporting radiologist and histopathologists, although all followed 
standard protocols employed at our institution, and undergo robust quality control measures. Visualisation of 
lesions was used to define the presence of malignancy in some cases, and although this was restricted to clear 
papillary lesions, there is an inherent limitation when a biopsy is not taken. The study data is also from a single 
institution, with retrospective data collection, and lacked a comprehensive account of potential aetiological 
risk factors for each patient. Future work could benefit from prospective data collection, standardised 
reporting on URS and pathological specimens, and multi-institutional data collection, to further improve 
statistical power and clinical applicability.   
CONCLUSION 
Our study represents the largest series in the UK to evaluate and quantify the predictive capabilities of the pre-
operative and intra-operative parameters in the diagnosis of UUTUC. We support the strategy whereby voided 
urine cytology and CT are useful as screening tools to identify at-risk patients. When abnormalities were 
detected in both preoperative voided cytology and CT, malignancy was confirmed in 85% cases. URS is 
imperative in identifying benign cases, particularly when the CT findings represent the only abnormal 
preoperative investigation. In the presence of a normal CT and voided urine cytology, we propose that a 
clinical judgment can be made for not performing a URS, provided that individual patient risk factors are also 
taken into account.  
Selective urine cytology does not appear to clinically improve the prediction of UUTUC. However, URS and 
biopsy remains a valuable confirmatory tool for diagnosis, therapy and guiding surgical management. Our 
results provide quantitation of the current diagnostic tools utilized in clinical practice, and in combination with 
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Table 1: Patient demographics and characteristics   































































Key: (*) denotes statistical significance (p <0.05) 
 
Figure 2: Distribution of voided and selective urine cytology results according to nephroureterectomy  







Table 2: CT findings and prediction of UUTUC. 
CT           Malignant status (%) 
 Benign  Malignant Total 
Normal  15 (75)*  5 (25)* 20 
Abnormal 
 Hydronephrosis/hydroureter 
 Ureteric thickening 





















Total   155 
Single findings on CT urogram:  Benign  Malignant Total 
Hydronephrosis  8 (47)  9 (53) 17 
Thickening  5 (56)  4 (44) 9 
Filling Defect or Soft Tissue Mass   12 (24)*  37 (76)* 49 
Key: Malignant status is determined by the presence of UUTUC observed on URS, and/or histologically defined 
from biopsies taken endoscopically or following nephroureterectomy. CT reports were available in 155 out of 
160 patients. The term “abnormal” refers to the detection of filling defect or soft tissue mass, 
hydronephrosis/hydroureter or ureteric thickening on CT. Percentages of row totals are denoted in brackets. (*) 
denotes a statistically significant difference between columns.  
 







Voided Urine Cytology (%) Selective Urine Cytology (%) 
Negative Atypical or Positive Negative Atypical or Positive 
Benign Malignant Benign Malignant Benign Malignant Benign Malignant 
Normal 5 (100) 0 (0) 5 (71) 2 (29) 10 (100) 0 (0) 4 (80) 1 (20) 
Relevant 
Pathology 9 (56) 7 (44) 2 (22) 7 (78) 6 (50) 6 (50) 2 (20) 8 (80) 
Filling 
Defect/Mass 19 (53) 17 (47) 6 (15) 33 (85) 19 (61) 12 (39) 8 (15) 47 (85) 
Table 4: Distribution of ureteroscopic biopsy and post-nephroureterectomy specimen histopathology, 
stratified according to tumour grade and stage 

































































Key: +UUTUC NOS denotes malignant UUTUC not otherwise specified. 
 
 
Figure 3: Comparison of ureteroscopic biopsy and post-operative nephroureterectomy specimen grade (left) 
and stage (right) 






Table 5: Multivariable regression analysis of pre-operative variables predicting the presence of UUTUC  
Variable Exp(B) 95% CI p-value 
Preoperative factors 
Male vs. Female (Ref) 
Age 







or ureteric thickening 
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